First North Dakota Quarterly Drug Price Transparency Reports Due in October
FDA Law Blog
SEPTEMBER 12, 2021
Schlanger — Earlier this year, North Dakota enacted a prescription drug price transparency reporting law, HB 1032 , that became effective on August 1, 2021. The new law also requires manufacturers to submit WAC price increase reports and new drug WAC reports. See our summary here.)
Let's personalize your content